Decisional reversal after antidepressant initiation: The role of early subjective experience in clinical practice

Abstract

Objective

To discuss how early subjective experiences following antidepressant initiation may influence treatment continuation and contribute to decisional reversal.

Conclusions

Early activating effects, particularly after selective serotonin reuptake inhibitor (SSRI) initiation, may function as interpretative signals leading patients to reconsider treatment initiation. Anticipatory guidance and early follow-up may help sustain adherence.

Keywords

antidepressants adherence early treatment effects decision-making treatment persistence

Get full access to this article

View all access options for this article.

References

Del Pino-Sedeño

Infante-Ventura

Hernández-González

, et al. Sociodemographic and clinical predictors of adherence to antidepressants in depressive disorders: a systematic review with a meta-analysis. Front Pharmacol 2024; 15: 1327155. https://doi.org/10.3389/fphar.2024.1327155

Infante-Ventura

Rodríguez-Díaz

García Bello

MÁ

, et al. Analysis of therapeutic adherence to antidepressants and associated factors in patients with depressive disorder: a population-based cohort study. J Affect Disord 2025; 385: 119443. https://doi.org/10.1016/j.jad.2025.119443

Bull

Hunkeler

, et al. Discontinuation of use and switching of antidepressants: influence of patient–physician communication. JAMA 2002; 288(11): 1403–1409. https://doi.org/10.1001/jama.288.11.1403

Olfson

Marcus

Tedeschi

, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006; 163(1): 101–108. https://doi.org/10.1176/appi.ajp.163.1.101

Alarcon-Ruiz

Zafra-Tanaka

Diaz-Barrera

, et al. Effects of decision aids for depression treatment in adults: systematic review. BJPsych Bull 2022; 46(3): 125–134. https://doi.org/10.1192/bjb.2020.130

LeBlanc

Herrin

Williams

, et al. Shared decision making for antidepressants in primary care: a cluster randomized trial. JAMA Intern Med 2015; 175(11): 1761–1770. https://doi.org/10.1001/jamainternmed.2015.5214

Sinclair

Christmas

Hood

, et al. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry 2009; 194(6): 483–490. https://doi.org/10.1192/bjp.bp.107.048371

Rief

Bingel

Schedlowski

, et al. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Ther 2011; 90(5): 722–726. https://doi.org/10.1038/clpt.2011.204

Horne

Weinman

. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47(6): 555–567. https://doi.org/10.1016/S0022-3999(99)00057-4

10.

Zolnierek

KBH

DiMatteo

. Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009; 47(8): 826–834. https://doi.org/10.1097/MLR.0b013e31819a5acc

11.

Simon

VonKorff

Rutter

, et al. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000; 320(7234): 550–554. https://doi.org/10.1136/bmj.320.7234.550